Parthenon Therapeutics scoops up $65m Series A

Parthenon Therapeutics, a biotech company, has raised $65 million in Series A financing.

Parthenon Therapeutics, a biotech company, has raised $65 million in Series A financing. Northpond Ventures, Pfizer Ventures, and Taiho Ventures led the round.

Source: Press Release